大脑到心脏的胆能突触 - - 信号传递介于缺血性中风引起的心房动
Yingran Liang1,2, Gongxin Wang3,4, Siwen Fan1,2
1State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Beihua South Road, JingHai District, Tianjin 301617, China.
Theranostics
|October 31, 2024
概括
这项研究开发了一种针对中风引起的心房动 (AF) 的老鼠模型,并发现Wenxin Keli (WK) 通过调节胆-信号来有效治疗它. 基,特别是它的成分迪奥辛,通过抑制通道来缓解AF.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与中风相关的心血管疾病,特别是心房动 (AF),是严重的临床问题.
- 对于中风诱导的AF缺乏实验模型,这阻碍了对这种中风心脏综合征 (SHS) 的研究.
研究的目的:
- 为了建立由缺血性中风引起的AF (ISIAF) 的老鼠模型.
- 调查温凯利 (WK) 在治疗ISIAF时的疗效和机制.
- 在SHS中识别WK的活性成分和分子标.
主要方法:
- 中脑动脉封闭/再输模型用于亚急性脑缺血.
- 电生理学,ex vivo光学映射,RNA-seq,RT-PCR,IHC和IF用于机械研究.
- UPLC/Q-TOF-MS,分子对接和全细胞补丁记录以识别WK的活性成分和目标.
主要成果:
- 缺血性中风诱导了心房电动不稳定,改变了动力电位的持续时间和导电异质性.
- WK治疗缓解了这些异常.
- 胆固醇突触和L型通道信号通路被确定为ISIAF的关键,而迪奥辛被确定为抑制ICa-L的WK的主要活性成分.
结论:
- 为ISIAF建立了一个有效的实验模型,反映了中风后的临床心房电生理学.
- 胆固醇-信号通路是ISIAF中脑心综合征的核心.
- 温辛凯利通过其成分迪奥辛,通过调节这种途径并抑制L型通道,部分逆转ISIAF.
相关概念视频
G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K
Cholinergic Neurons: Neurotransmission
2.6K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
2.6K
Mechanism of Cardiac Arrhythmias
892
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
892
Chemical Synapses
8.7K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.7K
Antihypertensive Drugs: Action of Calcium Channel Blockers
461
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
461
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
618
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
618


